FI963674A0 - Rekombinant-DNA-adenovirus, som kodar för hjärnhärstammande neurotrofisk faktor (BDNF) - Google Patents
Rekombinant-DNA-adenovirus, som kodar för hjärnhärstammande neurotrofisk faktor (BDNF)Info
- Publication number
- FI963674A0 FI963674A0 FI963674A FI963674A FI963674A0 FI 963674 A0 FI963674 A0 FI 963674A0 FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A0 FI963674 A0 FI 963674A0
- Authority
- FI
- Finland
- Prior art keywords
- bdnf
- recombinant dna
- neurotrophic factor
- derived neurotrophic
- adenovirus encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403191A FR2717496B1 (fr) | 1994-03-18 | 1994-03-18 | Virus recombinants, préparation et utilisation en thérapie génique. |
PCT/FR1995/000250 WO1995025804A1 (fr) | 1994-03-18 | 1995-03-02 | Adenovirus recombinants codant pour le facteur neurotrophique derive du cerveau (bdnf) |
Publications (2)
Publication Number | Publication Date |
---|---|
FI963674A FI963674A (sv) | 1996-09-17 |
FI963674A0 true FI963674A0 (sv) | 1996-09-17 |
Family
ID=9461190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963674A FI963674A0 (sv) | 1994-03-18 | 1996-09-17 | Rekombinant-DNA-adenovirus, som kodar för hjärnhärstammande neurotrofisk faktor (BDNF) |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0750676A1 (sv) |
JP (1) | JPH09510358A (sv) |
KR (1) | KR970701784A (sv) |
AU (1) | AU703793B2 (sv) |
CA (1) | CA2184200A1 (sv) |
FI (1) | FI963674A0 (sv) |
FR (1) | FR2717496B1 (sv) |
IL (1) | IL112992A0 (sv) |
MX (1) | MX9603490A (sv) |
NO (1) | NO963559L (sv) |
WO (1) | WO1995025804A1 (sv) |
ZA (1) | ZA952244B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830857A (en) * | 1995-07-14 | 1998-11-03 | Amgen Inc. | Method of treating epilepsy |
FR2753379B1 (fr) | 1996-09-13 | 1998-10-30 | Rhone Poulenc Rorer Sa | Methode de traitement de la sclerose laterale amyotrophique |
DE60137414D1 (de) * | 2000-05-05 | 2009-03-05 | Univ City | Zusammensetzungen zur stimulierung der regeneration und der wiederherstellung des nervensystems durch regulierung der arginase 1- und polyamin-synthese |
US20210079050A1 (en) * | 2018-02-20 | 2021-03-18 | Carmel Haifa University Economic Corporation Ltd. | Compositions and methods for delivery and expression of small inhibitory peptides and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0755682A1 (en) * | 1991-07-10 | 1997-01-29 | Regeneron Pharmaceuticals, Inc. | Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules |
US5733871A (en) * | 1991-11-08 | 1998-03-31 | The General Hospital Corporation | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
WO1994003199A1 (en) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
WO1994008026A1 (en) * | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
FR2704234B1 (fr) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | Virus recombinants, preparation et utilisation en therapie genique. |
-
1994
- 1994-03-18 FR FR9403191A patent/FR2717496B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-02 AU AU18962/95A patent/AU703793B2/en not_active Ceased
- 1995-03-02 EP EP95911371A patent/EP0750676A1/fr not_active Ceased
- 1995-03-02 KR KR1019960705207A patent/KR970701784A/ko not_active Application Discontinuation
- 1995-03-02 JP JP7524417A patent/JPH09510358A/ja active Pending
- 1995-03-02 MX MX9603490A patent/MX9603490A/es not_active Application Discontinuation
- 1995-03-02 WO PCT/FR1995/000250 patent/WO1995025804A1/fr not_active Application Discontinuation
- 1995-03-02 CA CA002184200A patent/CA2184200A1/fr not_active Abandoned
- 1995-03-14 IL IL11299295A patent/IL112992A0/xx unknown
- 1995-03-17 ZA ZA952244A patent/ZA952244B/xx unknown
-
1996
- 1996-08-26 NO NO963559A patent/NO963559L/no not_active Application Discontinuation
- 1996-09-17 FI FI963674A patent/FI963674A0/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA952244B (en) | 1996-01-16 |
FI963674A (sv) | 1996-09-17 |
FR2717496B1 (fr) | 1996-04-12 |
AU1896295A (en) | 1995-10-09 |
WO1995025804A1 (fr) | 1995-09-28 |
EP0750676A1 (fr) | 1997-01-02 |
MX9603490A (es) | 1997-03-29 |
FR2717496A1 (fr) | 1995-09-22 |
IL112992A0 (en) | 1995-06-29 |
JPH09510358A (ja) | 1997-10-21 |
AU703793B2 (en) | 1999-04-01 |
CA2184200A1 (fr) | 1995-09-28 |
KR970701784A (ko) | 1997-04-12 |
NO963559L (no) | 1996-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE191146T1 (de) | Rekombinanten faktor viii enthaltendes stabilisiertes albuminfreies präparat mit niedrigem zuckergehalt | |
GB2347930B (en) | IGF-1 receptor interacting proteins (IIPs), genes coding therefor and uses thereof | |
BR9709297A (pt) | Controlador de falta de bombeamento | |
EE04684B1 (et) | Moraxella catarrhalis vlismembraani proteiin-106polpeptiid, geenijrjestus ja selle kasutamine | |
FI924091A0 (fi) | Autoriseringsprotokoll som foersiktighetshjaelpmedel. | |
HK1033149A1 (en) | Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use. | |
DE69310280D1 (de) | Aluminiumoxid-, Calciumoxid-, Yttriumoxid-Dichtungsmittel-Zusammensetzung | |
FI963674A0 (sv) | Rekombinant-DNA-adenovirus, som kodar för hjärnhärstammande neurotrofisk faktor (BDNF) | |
AU1381299A (en) | Novel genes encoding transporter-like molecules | |
TR199500915A2 (tr) | Peptidler. | |
NO973422D0 (no) | Recombinant C140-reseptor, dens agonister og antagonister og nukleinsyrer som koder for reseptoren | |
NL1009152A1 (nl) | Aromatische polysulfonharssamenstelling. | |
DE59712799D1 (de) | Aav-dna mit helfervirus-sequenzen | |
NO901434L (no) | Neurotrofiske peptider. | |
EP0958304A4 (en) | NUCLEOTIDE SEQUENCE ENCODING PROTEIN TYPE CD33 | |
DE59813562D1 (de) | Pigmentzubereitungen für das Ink-Jet-Verfahren | |
DE69738977D1 (de) | Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung | |
NO20022542L (no) | DNA som koder for et nytt Ets-polypeptid | |
AU5999099A (en) | Dnas encoding novel polypeptides | |
GB9606983D0 (en) | Ultra-violet (u.v) bubble mix | |
FI884556A (fi) | Rekombinantplasmid-dna ppr-ifn 1-13, som kodas foer syntes av maenniskans fibroblast- 1-interferon, foerfarande foer framstaellning daerav och e.coli innehaollande detta. | |
ITPD970057A0 (it) | Carrello per randa | |
EP1251171A4 (en) | NOVEL ENDOPLASMIC PROTEIN WITH LOCALIZED RETICULUM, REMEDIES CONTAINING THIS PROTEIN FOR DISEASES ASSOCIATED WITH GLYCOPROTEIC ANOMALY, DNA ENCODING SAME, AND GENETIC REMEDIES CONTAINING THIS DNA FOR THE TREATMENT OF DISEASES ASSOCIATED WITH GLOBAL ANOMALY | |
SE9401043D0 (sv) | Hamnar (Bassänger), rening, cirk., uppvärmning | |
IL140030A0 (en) | Polypeptides dna molecules encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |